News Home

VBI Vaccines Inc (VBIV) Down 1.63% in Premarket Trading

Thursday, August 18, 2022 08:47 AM | InvestorsObserver Analysts
VBI Vaccines Inc (VBIV) Down 1.63% in Premarket Trading

VBI Vaccines Inc (VBIV) is down Thursday morning, with the stock falling -1.63% in pre-market trading to 1.21. VBIV's short-term technical score of 22 indicates that the stock has traded less bullishly over the last month than 78% of stocks on the market. In the Biotechnology industry, which ranks 117 out of 146 industries, VBIV ranks higher than 30% of stocks. VBI Vaccines Inc has risen 55.70% over the past month, closing at $0.94 on July 21. During this period of time, the stock fell as low as $0.80 and as high as $1.35. VBIV has an average analyst recommendation of Strong Buy. The company has an average price target of $6.00.

Overall Score - 47
VBIV has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on VBIV!
VBI Vaccines Inc has a Long-Term Technical rank of 46. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 54% of the market scoring higher. In the Biotechnology industry which is number 83 by this metric, VBIV ranks better than 83% of stocks.

Important Dates for Investors in VBIV:

-VBI Vaccines Inc is set to release earnings on 11/6/2022. Over the last 12 months, the company has reported EPS of $-0.39. -We do not have a set dividend date for VBI Vaccines Inc at this time. Click Here To Get The Full Report on VBI Vaccines Inc (VBIV)

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App